Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer

NCT03400709 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Cisplatin Adverse Reaction
Hearing Loss Ototoxic

Interventions

DRUG: N Acetylcysteine
DRUG: Placebo Oral Tablet

Sponsor

Hospital San Juan de Dios, Santiago